Go to
JCI Insight
Citations to this article
Joanne R. Doherty, John L. Cleveland
Published September 3, 2013
Citation Information: J Clin Invest. 2013;123(9):3685-3692. https://doi.org/10.1172/JCI69741.
Citation Information: J Clin Invest. 2013;123(9):3685-3692. https://doi.org/10.1172/JCI69741.
Abstract
Lactate, once considered a waste product of glycolysis, has emerged as a critical regulator of cancer development, maintenance, and metastasis. Indeed, tumor lactate levels correlate with increased metastasis, tumor recurrence, and poor outcome. Lactate mediates cancer cell intrinsic effects on metabolism and has additional non–tumor cell autonomous effects that drive tumorigenesis. Tumor cells can metabolize lactate as an energy source and shuttle lactate to neighboring cancer cells, adjacent stroma, and vascular endothelial cells, which induces metabolic reprogramming. Lactate also plays roles in promoting tumor inflammation and in functioning as a signaling molecule that stimulates tumor angiogenesis. Here we review the mechanisms of lactate production and transport and highlight emerging evidence indicating that targeting lactate metabolism is a promising approach for cancer therapeutics.
Authors
Joanne R. Doherty, John L. Cleveland
Total citations by year
Citation information
Citations to this article in year 2017 (36)
| Title and authors | Publication | Year |
|---|---|---|
|
Metabolism shapes the tumor microenvironment
M Reina-Campos, J Moscat, M Diaz-Meco |
Current Opinion in Cell Biology | 2017 |
|
Targeting Metabolism for Cancer Therapy
A Luengo, DY Gui, MG Heiden |
Cell Chemical Biology | 2017 |
|
Metabolic Interactions in the Tumor Microenvironment
CA Lyssiotis, AC Kimmelman |
Trends in Cell Biology | 2017 |
|
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
A Angelin, L Gil-de-Gómez, S Dahiya, J Jiao, L Guo, MH Levine, Z Wang, WJ Quinn, PK Kopinski, L Wang, T Akimova, Y Liu, TR Bhatti, R Han, BL Laskin, JA Baur, IA Blair, DC Wallace, WW Hancock, UH Beier |
Cell Metabolism | 2017 |
|
Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Y Sunami, A Rebelo, J Kleeff |
Cancers | 2017 |
|
VDAC–Tubulin, an Anti-Warburg Pro-Oxidant Switch
EN Maldonado |
Frontiers in Oncology | 2017 |
|
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
S Gupta, A Roy, BS Dwarakanath |
Frontiers in Oncology | 2017 |
|
Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells
H Chen, DC Chan |
Cell Metabolism | 2017 |
|
Metabolic Coupling and the Reverse Warburg Effect in Cancer, implications for novel biomarker and anticancer agent development
L Wilde, M Roche, M Domingo-Vidal, K Tanson, N Philp, J Curry, U Martinez-Outschoorn |
Seminars in Oncology | 2017 |
|
Dysbiosis of the microbiome in gastric carcinogenesis
N Castaño-Rodríguez, KL Goh, KM Fock, HM Mitchell, NO Kaakoush |
Scientific Reports | 2017 |
|
Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy
M Tomasetti, W Lee, L Santarelli, J Neuzil |
Experimental & molecular medicine | 2017 |
|
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
L Jin, J Chun, C Pan, GN Alesi, D Li, KR Magliocca, Y Kang, ZG Chen, DM Shin, FR Khuri, J Fan, S Kang |
Oncogene | 2017 |
|
HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
P Miikkulainen, H Högel, K Rantanen, T Suomi, P Kouvonen, LL Elo, PM Jaakkola |
Cancer & Metabolism | 2017 |
|
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
D Ciavardelli, M Bellomo, A Consalvo, C Crescimanno, V Vella |
BioMed Research International | 2017 |
|
FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells
EJ Rellinger, BT Craig, AL Alvarez, HL Dusek, KW Kim, J Qiao, DH Chung |
Surgery | 2017 |
|
Composite Hydrogels with Engineered Microdomains for Optical Glucose Sensing at Low Oxygen Conditions
L Bornhoeft, A Biswas, M McShane |
Biosensors | 2017 |
|
Peroxisomal Dysfunction in Age-Related Diseases
CM Cipolla, IJ Lodhi |
Trends in Endocrinology & Metabolism | 2017 |
|
pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma
JP Caruso, BJ Koch, PD Benson, E Varughese, MD Monterey, AE Lee, AM Dave, S Kiousis, AE Sloan, SP Mathupala |
Neoplasia (New York, N.Y.) | 2017 |
|
M2-like macrophage polarization in high lactic acid-producing head and neck cancer
T Ohashi, M Aoki, H Tomita, T Akazawa, K Sato, B Kuze, K Mizuta, A Hara, H Nagaoka, N Inoue, Y Ito |
Cancer Science | 2017 |
|
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
HS Sabnis, RR Somasagara, KD Bunting |
Genes & development | 2017 |
|
MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect
N Shtraizent, C DeRossi, S Nayar, R Sachidanandam, LS Katz, A Prince, AP Koh, A Vincek, Y Hadas, Y Hoshida, DK Scott, E Eliyahu, HH Freeze, KC Sadler, J Chu |
eLife | 2017 |
|
Glycolytic reliance promotes anabolism in photoreceptors
Y Chinchore, T Begaj, D Wu, E Drokhlyansky, CL Cepko |
eLife | 2017 |
|
Perspective on the dynamics of cancer
Y Derbal |
Theoretical Biology and Medical Modelling | 2017 |
|
Tumour acidosis: from the passenger to the driver's seat
C Corbet, O Feron |
Nature Reviews Cancer | 2017 |
|
Mitochondrial and glycolytic metabolic compartmentalization in Diffuse Large B Cell Lymphoma
M Gooptu, D Whitaker-Menezes, J Sprandio, M Domingo-Vidal, Z Lin, G Uppal, J Gong, R Fratamico, B Leiby, A Dulau-Florea, J Caro, U Martinez-Outschoorn |
Seminars in Oncology | 2017 |
|
The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy
Y Fu, S Liu, S Yin, W Niu, W Xiong, M Tan, G Li, M Zhou |
Oncotarget | 2017 |
|
H 2 S-induced S -sulfhydration of lactate dehydrogenase A (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells
AA Untereiner, G Oláh, K Módis, MR Hellmich, C Szabo |
Biochemical Pharmacology | 2017 |
|
PIK3CA mutant tumors depend on oxoglutarate dehydrogenase
N Ilic, K Birsoy, AJ Aguirre, N Kory, ME Pacold, S Singh, SE Moody, JD DeAngelo, NA Spardy, E Freinkman, BA Weir, A Tsherniak, GS Cowley, DE Root, JM Asara, F Vazquez, HR Widlund, DM Sabatini, WC Hahn |
Proceedings of the National Academy of Sciences | 2017 |
|
Intratumoral lactate metabolism in barrett’s esophagus and adenocarcinoma
H Huhta, O Helminen, S Palomäki, JH Kauppila, J Saarnio, PP Lehenkari, TJ Karttunen |
Oncotarget | 2017 |
|
MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy
M Beloueche-Babari, S Wantuch, TC Galobart, M Koniordou, HG Parkes, V Arunan, YL Chung, TR Eykyn, PD Smith, MO Leach |
Cancer research | 2017 |
|
The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism
MA Silvers, S Deja, N Singh, RA Egnatchik, J Sudderth, X Luo, MS Beg, SC Burgess, RJ DeBerardinis, DA Boothman, ME Merritt |
The Journal of biological chemistry | 2017 |
|
Drosophila as a Model to Study the Link between Metabolism and Cancer
H Herranz, S Cohen |
Journal of Developmental Biology | 2017 |
|
IL-1/inhibitory κB kinase ε–induced glycolysis augment epithelial effector function and promote allergic airways disease
, R Aboushousha, C van de Wetering, SB Chia, E Amiel, RW Schneider, JL van der Velden, KG Lahue, DA Hoagland, DT Casey, N Daphtary, JL Ather, MJ Randall, M Aliyeva, KE Black, DG Chapman, LK Lundblad, DH McMillan, AE Dixon, V Anathy, CG Irvin, ME Poynter, EF Wouters, PM Vacek, M Henket, F Schleich, R Louis, A van der Vliet, YM Janssen-Heininger |
Journal of Allergy and Clinical Immunology | 2017 |
|
Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor
GA Vitiello, BD Medina, S Zeng, TG Bowler, JQ Zhang, JK Loo, NJ Param, M Liu, AJ Moral, JN Zhao, F Rossi, CR Antonescu, VP Balachandran, JR Cross, RP DeMatteo |
Clinical cancer research | 2017 |
|
Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A
AM Altamimi, AM Alafeefy, A Balode, I Vozny, A Pustenko, ME Shikh, FA Alasmary, SA Abdel-Gawad, R Žalubovskis |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2017 |
|
Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
Achreja A, Zhao H, Yang L, Yun TH, Marini J, Nagrath D |
Metabolic Engineering | 2017 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)